Literature DB >> 28834477

Trial of Minocycline in Clinically Isolated Syndrome of Multiple Sclerosis.

Luanne M Metz1, Misha Eliasziw2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28834477     DOI： 10.1056/NEJMc1708486

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  6 in total

1.  Key driver genes as potential therapeutic targets in renal allograft rejection.

Authors:  Zhengzi Yi; Karen L Keung; Li Li; Min Hu; Bo Lu; Leigh Nicholson; Elvira Jimenez-Vera; Madhav C Menon; Chengguo Wei; Stephen Alexander; Barbara Murphy; Philip J O'Connell; Weijia Zhang
Journal:  JCI Insight       Date:  2020-08-06

2.  2017 revisions of McDonald criteria shorten the time to diagnosis of multiple sclerosis in clinically isolated syndromes.

Authors:  Lorenzo Gaetani; Luca Prosperini; Andrea Mancini; Paolo Eusebi; Maria Chiara Cerri; Carlo Pozzilli; Paolo Calabresi; Paola Sarchielli; Massimiliano Di Filippo
Journal:  J Neurol       Date:  2018-09-08       Impact factor: 4.849

Review 3.  Microglia, Lifestyle Stress, and Neurodegeneration.

Authors:  Charlotte Madore; Zhuoran Yin; Jeffrey Leibowitz; Oleg Butovsky
Journal:  Immunity       Date:  2020-01-07       Impact factor: 31.745

Review 4.  Immunopathological Factors Associated with Disability in Multiple Sclerosis.

Authors:  Erdem Tüzün
Journal:  Noro Psikiyatr Ars       Date:  2018       Impact factor: 1.339

Review 5.  Microglial signatures and their role in health and disease.

Authors:  Oleg Butovsky; Howard L Weiner
Journal:  Nat Rev Neurosci       Date:  2018-10       Impact factor: 34.870

Review 6.  Drug Treatment of Clinically Isolated Syndrome.

Authors:  Moritz Förster; Jonas Graf; Jan Mares; Orhan Aktas; Hans-Peter Hartung; David Kremer
Journal:  CNS Drugs       Date:  2019-07       Impact factor: 6.497
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.